Microbot Medical Net Income vs. Current Ratio
| MBOT Stock | USD 2.15 0.05 2.38% |
Net Loss | First Reported 1991-03-31 | Previous Quarter -3.5 M | Current Value -3.6 M | Quarterly Volatility 2.8 M |
For Microbot Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Microbot Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Microbot Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Microbot Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Microbot Medical over time as well as its relative position and ranking within its peers.
Check out Correlation Analysis. Is there potential for Health Care Equipment & Supplies market expansion? Will Microbot introduce new products? Factors like these will boost the valuation of Microbot Medical. Expected growth trajectory for Microbot significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Microbot Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate Microbot Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Microbot Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Microbot Medical's market price to deviate significantly from intrinsic value.
Understanding that Microbot Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Microbot Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Microbot Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Microbot Medical Current Ratio vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Microbot Medical's current stock value. Our valuation model uses many indicators to compare Microbot Medical value to that of its competitors to determine the firm's financial worth. Microbot Medical is regarded third in net income category among its peers. It is rated below average in current ratio category among its peers . At this time, Microbot Medical's Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Microbot Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Microbot Current Ratio vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Microbot Medical |
| = | (11.44 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Microbot Medical |
| = | 5.60 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Microbot Current Ratio Comparison
Microbot Medical is currently under evaluation in current ratio category among its peers.
Microbot Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Microbot Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Microbot Medical will eventually generate negative long term returns. The profitability progress is the general direction of Microbot Medical's change in net profit over the period of time. It can combine multiple indicators of Microbot Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -10.5 M | -9.9 M | |
| Income Before Tax | -10.3 M | -10.8 M | |
| Total Other Income Expense Net | 209.3 K | 219.8 K | |
| Net Loss | -10.3 M | -10.8 M | |
| Income Tax Expense | 163.8 K | 172 K | |
| Net Loss | -13.2 M | -13.8 M | |
| Non Operating Income Net Other | 730.5 K | 802.2 K | |
| Net Loss | -15.1 M | -15.9 M | |
| Interest Income | 243.8 K | 256 K | |
| Net Interest Income | 209.3 K | 219.8 K | |
| Change To Netincome | 1.2 M | 1.5 M | |
| Net Loss | (0.66) | (0.69) | |
| Income Quality | 0.89 | 0.94 | |
| Net Income Per E B T | 1.15 | 0.80 |
Microbot Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Microbot Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Microbot Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Microbot Medical's important profitability drivers and their relationship over time.
Microbot Medical Earnings Estimation Breakdown
The calculation of Microbot Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Microbot Medical is estimated to be -0.0875 with the future projection ranging from a low of -0.0925 to a high of -0.0825. Please be aware that this consensus of annual earnings estimates for Microbot Medical is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.09 Lowest | Expected EPS | -0.08 Highest |
Microbot Medical Earnings Projection Consensus
Suppose the current estimates of Microbot Medical's value are higher than the current market price of the Microbot Medical stock. In this case, investors may conclude that Microbot Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Microbot Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 3 | 76.62% | 0.0 | -0.0875 | -0.45 |
Microbot Medical Earnings per Share Projection vs Actual
Actual Earning per Share of Microbot Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Microbot Medical predict the company's earnings will be in the future. The higher the earnings per share of Microbot Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Microbot Medical Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Microbot Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Microbot Medical should always be considered in relation to other companies to make a more educated investment decision.Microbot Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Microbot Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-07 | 2025-09-30 | -0.08 | -0.07 | 0.01 | 12 | ||
2025-08-12 | 2025-06-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2025-05-14 | 2025-03-31 | -0.15 | -0.08 | 0.07 | 46 | ||
2025-03-25 | 2024-12-31 | -0.18 | -0.2 | -0.02 | 11 | ||
2024-11-12 | 2024-09-30 | -0.17 | -0.2 | -0.03 | 17 | ||
2024-08-14 | 2024-06-30 | -0.17 | -0.17 | 0.0 | 0 | ||
2024-05-15 | 2024-03-31 | -0.17 | -0.17 | 0.0 | 0 | ||
2024-03-27 | 2023-12-31 | -0.25 | -0.17 | 0.08 | 32 | ||
2023-11-13 | 2023-09-30 | -0.25 | -0.21 | 0.04 | 16 | ||
2023-08-14 | 2023-06-30 | -0.31 | -0.25 | 0.06 | 19 | ||
2023-05-17 | 2023-03-31 | -0.45 | -0.36 | 0.09 | 20 | ||
2023-03-31 | 2022-12-31 | -0.47 | -0.47 | 0.0 | 0 | ||
2022-11-14 | 2022-09-30 | -0.51 | -0.49 | 0.02 | 3 | ||
2022-08-15 | 2022-06-30 | -0.45 | -0.49 | -0.04 | 8 | ||
2022-05-16 | 2022-03-31 | -0.42 | -0.45 | -0.03 | 7 | ||
2022-03-31 | 2021-12-31 | -0.37 | -0.54 | -0.17 | 45 | ||
2021-11-15 | 2021-09-30 | -0.36 | -0.36 | 0.0 | 0 | ||
2021-08-16 | 2021-06-30 | -0.35 | -0.35 | 0.0 | 0 | ||
2021-05-17 | 2021-03-31 | -0.33 | -0.34 | -0.01 | 3 | ||
2021-03-31 | 2020-12-31 | -0.34 | -0.37 | -0.03 | 8 | ||
2020-11-16 | 2020-09-30 | -0.28 | -0.35 | -0.07 | 25 | ||
2020-08-14 | 2020-06-30 | -0.27 | -0.26 | 0.01 | 3 | ||
2020-05-15 | 2020-03-31 | -0.28 | -0.31 | -0.03 | 10 | ||
2020-03-26 | 2019-12-31 | -0.33 | -0.33 | 0.0 | 0 | ||
2019-11-14 | 2019-09-30 | -0.36 | -0.44 | -0.08 | 22 | ||
2019-08-14 | 2019-06-30 | -0.41 | -0.36 | 0.05 | 12 | ||
2019-05-15 | 2019-03-31 | -0.42 | -0.48 | -0.06 | 14 | ||
2019-03-31 | 2018-12-31 | -0.59 | -0.72 | -0.13 | 22 | ||
2018-11-14 | 2018-09-30 | -0.6 | -0.58 | 0.02 | 3 | ||
2018-08-14 | 2018-06-30 | -0.6 | -0.6 | 0.0 | 0 | ||
2018-04-02 | 2018-03-31 | -0.6 | -0.45 | 0.15 | 25 | ||
2018-03-22 | 2017-12-31 | -0.04 | -0.03 | 0.01 | 25 | ||
2016-11-03 | 2016-09-30 | -85.05 | -59.4 | 25.65 | 30 | ||
2016-08-15 | 2016-06-30 | -90.45 | 8.1 | 98.55 | 108 | ||
2016-05-10 | 2016-03-31 | -101.25 | -132.3 | -31.05 | 30 | ||
2016-03-15 | 2015-12-31 | -142.56 | -129.6 | 12.96 | 9 | ||
2015-11-02 | 2015-09-30 | -142.56 | -145.8 | -3.24 | 2 | ||
2015-08-06 | 2015-06-30 | -139.32 | -145.8 | -6.48 | 4 | ||
2015-05-05 | 2015-03-31 | -226.8 | -226.8 | 0.0 | 0 | ||
2015-03-13 | 2014-12-31 | -189 | -178.2 | 10.8 | 5 | ||
2014-11-05 | 2014-09-30 | -262.44 | -64.8 | 197.64 | 75 | ||
2014-08-12 | 2014-06-30 | -230.04 | -356.4 | -126.36 | 54 | ||
2014-05-14 | 2014-03-31 | -194.4 | -226.8 | -32.4 | 16 | ||
2014-03-12 | 2013-12-31 | -210.6 | -210.6 | 0.0 | 0 | ||
2013-11-05 | 2013-09-30 | -218.7 | -275.4 | -56.7 | 25 | ||
2013-08-07 | 2013-06-30 | -263.25 | -243.0 | 20.25 | 7 | ||
2013-05-10 | 2013-03-31 | -216 | -275.4 | -59.4 | 27 | ||
2013-03-19 | 2012-12-31 | -221.4 | -113.4 | 108.0 | 48 | ||
2012-11-08 | 2012-09-30 | -230.04 | -874.8 | -644.76 | 280 | ||
2012-08-02 | 2012-06-30 | -405 | -356.4 | 48.6 | 12 | ||
2012-05-10 | 2012-03-31 | -421.2 | -729.0 | -307.8 | 73 | ||
2012-03-13 | 2011-12-31 | -588.6 | -696.6 | -108.0 | 18 | ||
2011-11-01 | 2011-09-30 | -729 | -502.2 | 226.8 | 31 | ||
2011-07-28 | 2011-06-30 | -688.5 | -469.8 | 218.7 | 31 | ||
2011-05-04 | 2011-03-31 | -891 | -680.4 | 210.6 | 23 | ||
2010-11-03 | 2010-09-30 | -1020.6 | -648.0 | 372.6 | 36 | ||
2010-08-10 | 2010-06-30 | -1198.8 | -648.0 | 550.8 | 45 | ||
2010-05-04 | 2010-03-31 | -1134 | -810.0 | 324.0 | 28 | ||
2010-03-11 | 2009-12-31 | -907.2 | -810.0 | 97.2 | 10 | ||
2009-11-05 | 2009-09-30 | -1093.5 | -810.0 | 283.5 | 25 | ||
2009-08-10 | 2009-06-30 | -1036.8 | -1134.0 | -97.2 | 9 | ||
2009-05-08 | 2009-03-31 | -1109.7 | -1620.0 | -510.3 | 45 | ||
2009-03-16 | 2008-12-31 | -1134 | -1782.0 | -648.0 | 57 | ||
2006-03-16 | 2005-12-31 | -1782 | -1134.0 | 648.0 | 36 | ||
2004-05-03 | 2004-03-31 | -1620 | -1134.0 | 486.0 | 30 | ||
1998-02-10 | 1997-12-31 | -4050 | -4212.0 | -162.0 | 4 | ||
1997-11-19 | 1997-09-30 | -3564 | -3240.0 | 324.0 | 9 | ||
1997-07-28 | 1997-06-30 | -4050 | -648.0 | 3402.0 | 84 | ||
1997-05-06 | 1997-03-31 | 81 | -4212.0 | -4293.0 | 5300 | ||
1997-02-06 | 1996-12-31 | -3726 | -4536.0 | -810.0 | 21 | ||
1996-01-22 | 1995-12-31 | -3645 | -3240.0 | 405.0 | 11 |
Use Microbot Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbot Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will appreciate offsetting losses from the drop in the long position's value.Microbot Medical Pair Trading
Microbot Medical Pair Trading Analysis
The ability to find closely correlated positions to Microbot Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbot Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbot Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbot Medical to buy it.
The correlation of Microbot Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbot Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbot Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbot Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Microbot Medical position
In addition to having Microbot Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Most Shorted Equities Thematic Idea Now
Most Shorted Equities
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 238 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.